Pembrolizumab Exacerbates Thyroid Diseases Shown on FDG PET/CT

被引：3
|
作者：
Wang, Xuezhu [1 ,2 ]
Wang, Jingnan [1 ,2 ]
Yang, Xu [3 ]
Zhao, Haitao [3 ]
Huo, Li [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Nucl Med, 1 Shuaifuyuan,Donghuamen St, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing Key Lab Mol Targeted Diag & Therapy Nucl, 1 Shuaifuyuan,Donghuamen St, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2020年 / 45卷 / 12期
基金：
中国国家自然科学基金;
关键词：
pembrolizumab; anti-PD-1; thyroid; FDGPET/CT; sarcomatoid hepatocellular carcinoma; HEPATOCELLULAR-CARCINOMA; TOMOGRAPHY; CANCER; LIVER;
D O I：
10.1097/RLU.0000000000003251
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1010 / 1012
页数：3
相关论文
共 50 条
  • [1] Solitary Nasopharyngeal Metastasis From Papillary Thyroid Carcinoma Shown on FDG PET/CT
    Xu, Anqi
    Jie, Xiao
    Xiu, Yan
    Shi, Hongcheng
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (05) : E425 - E427
  • [2] The Role of 18F-FDG PET/CT in the Management of the Autoimmune Thyroid Diseases
    Malkowski, Bogdan
    Serafin, Zbigniew
    Glonek, Rafal
    Suwala, Szymon
    Lopatto, Rita
    Junik, Roman
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [3] Primary Pericardial Angiosarcoma Shown on FDG PET/CT
    Shi, Ximin
    Li, Fang
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (12) : 973 - 975
  • [4] Uterine leiomyosarcoma metastatic to thyroid shown by 18F-FDG PET/CT imaging
    Gauthe, M.
    Dardel, N. Testart
    Nascimento, C.
    Trassard, M.
    Banal, A.
    Alberini, J. -L
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (02): : 113 - 115
  • [5] FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis
    Lu, Yang
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (02) : 167 - 168
  • [6] Pseudoprogression Shown on 18F-FDG PET/CT After Pembrolizumab Treatment in a Case of Metastatic Bladder Cancer
    Kaya, Fulya
    Komek, Halil
    Dursun, Ibrahim Hakki
    Senses, Veysi
    Guendogan, Cihan
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2025, 34 (01) : 70 - 72
  • [7] PET and PET/CT imaging in thyroid and adrenal diseases: an update
    Treglia, Giorgio
    Giovanella, Luca
    Rufini, Vittoria
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 12 (03): : 327 - 333
  • [8] Primary Squamous Cell Carcinoma of the Thyroid on FDG PET/CT
    Cai, Liang
    Chen, Yue
    Huang, Zhanwen
    Wu, Jingbo
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (11) : 1014 - 1016
  • [9] Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging
    Chen, Wengen
    Parsons, Molly
    Torigian, Drew A.
    Zhuang, Hongming
    Alavi, Abass
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (03) : 240 - 244
  • [10] Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact
    Bonabi, Sharouz
    Schmidt, Felix
    Broglie, Martina A.
    Haile, Sarah R.
    Stoeckli, Sandro J.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (12) : 2555 - 2560
12345